Erratum: In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valveendocarditis (JAMA Internal Medicine (2013) 173:16 (1495-1504) DOI: 10.1001/jamainternmed.2013.8203);In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis

JAMA Internal Medicine

Volumn 173, Issue 16, 2013, Pages 1495-1504

  Lalani, Tahaniyat ^a   Chu, Vivian H ^b   Park, Lawrence P ^b   Cecchi, Enrico ^c   Corey, G Ralph ^b   Durante Mangoni, Emanuele ^d   Fowler Jr , Vance G ^b   Gordon, David ^e   Grossi, Paolo ^f   Hannan, Margaret ^g   Hoen, Bruno ^h   Munõz, Patricia ⁱ   Rizk, Hussien ^j   Kanj, Souha S ^k   Selton Suty, Christine ^l   Sexton, Daniel J ^b   Spelman, Denis ^m   Ravasio, Veronica ⁿ   Tripodi, Marie Franco̧ise ^d   Wang, Andrew ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MARIA VITTORIA HOSPITAL   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e FLINDERS MEDICAL CENTRE   (Australia)

^f OSPEDALE DI CIRCOLO   (Italy)

^g MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^h Service de Maladies Infectieuses et Tropicales   (France)

ⁱ HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^j CAIRO UNIVERSITY   (Egypt)

^k AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^l CHU NANCY BRABOIS   (France)

^m ALFRED HOSPITAL   (Australia)

ⁿ OSPEDALI RIUNITI   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART VALVE REPLACEMENT; HOSPITALIZATION; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POST TREATMENT SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHETIC VALVE ENDOCARDITIS; SCHOOL CHILD; TREATMENT OUTCOME; AORTA VALVE; CLINICAL TRIAL; ENDOCARDITIS, BACTERIAL; FOLLOW UP; HEART VALVE PROSTHESIS; MIDDLE AGED; MITRAL VALVE; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; PROSTHESIS-RELATED INFECTIONS; REGISTER; SURGERY; TIME TO TREATMENT;

AORTIC VALVE; ENDOCARDITIS, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; REGISTRIES; TIME-TO-TREATMENT;

EID: 84883798157     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.8203     Document Type: Erratum

References (42)

1. Agnihotri AK, McGiffin DC, Galbraith AJ, O'Brien MF. The prevalence of infective endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg. 1995;110(6):1708-1724.
2. Calderwood SB, Swinski LA, Waternaux CM, Karchmer AW, Buckley MJ. Risk factors for the development of prosthetic valve endocarditis. Circulation. 1985;72(1):31-37. (Pubitemid 15069574)
3. Arvay A, Lengyel M. Incidence and risk factors of prosthetic valve endocarditis. Eur J Cardiothorac Surg. 1988;2(5):340-346.
4. Wang A, Athan E, Pappas PA, et al International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297(12):1354- 1361. (Pubitemid 46513236)
5. Bonow RO, Carabello BA, Chatterjee K, et al American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48(3):e1-e148. doi:10.1016/j.jacc.2006.05.021.
6. Habib G, Hoen B, Tornos P, et al ESC Committee for Practice Guidelines; endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30(19):2369-2413.
7. Attaran S, Chukwuemeka A, Punjabi PP, Anderson J. Do all patients with prosthetic valve endocarditis need surgery? Interact Cardiovasc Thorac Surg. 2012;15(6):1057-1061.
8. Calderwood SB, Swinski LA, Karchmer AW, Waternaux CM, Buckley MJ. Prosthetic valve endocarditis: analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg. 1986;92(4):776-783. (Pubitemid 17168274)
9. Yu VL, Fang GD, Keys TF, et al. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg. 1994;58(4):1073-1077. (Pubitemid 24342433)
10. Otaki M. Prosthetic valve endocarditis: surgical procedures and clinical outcome. Cardiovasc Surg. 1994;2(2):212-215. (Pubitemid 24144753)
11. Wolff M, Witchitz S, Chastang C, Régnier B, Vachon F. Prosthetic valve endocarditis in the ICU: prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision. Chest. 1995;108(3):688-694.
12. Ho HH, Siu CW, Yiu KH, Tse HF, Chui WH, Chow WH. Prosthetic valve endocarditis in a multicenter registry of Chinese patients. Asian Cardiovasc Thorac Ann. 2010;18(5):430-434.
13. John MD, Hibberd PL, Karchmer AW, Sleeper LA, Calderwood SB. Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis. 1998;26(6):1302-1309.
14. Sohail MR, Martin KR, Wilson WR, Baddour LM, Harmsen WS, Steckelberg JM. Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J Med. 2006;119(2):147-154. (Pubitemid 43151481)
15. Gordon SM, Serkey JM, Longworth DL, Lytle BW, Cosgrove DM III. Early onset prosthetic valve endocarditis: the Cleveland Clinic experience 1992-1997. Ann Thorac Surg. 2000;69(5):1388-1392. (Pubitemid 30434863)
16. Akowuah EF, Davies W, Oliver S, et al. Prosthetic valve endocarditis: early and late outcome following medical or surgical treatment. Heart. 2003;89(3):269-272. (Pubitemid 36241535)
17. Alonso-Valle H, Fariñas-Alvarez C, García-Palomo JD, et al. Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period. J Thorac Cardiovasc Surg. 2010;139(4):887-893.
18. Habib G, Tribouilloy C, Thuny F, et al. Prosthetic valve endocarditis: who needs surgery? a multicentre study of 104 cases. Heart. 2005;91(7):954-959. (Pubitemid 40874090)
19. Kuyvenhoven JP, van Rijk-Zwikker GL, Hermans J, Thompson J, Huysmans HA. Prosthetic valve endocarditis: analysis of risk factors for mortality. Eur J Cardiothorac Surg. 1994;8(8):420-424.
20. López J, Revilla A, Vilacosta I, et al. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J. 2007;28(6):760-765. (Pubitemid 46439227)
21. Chirouze C, Cabell CH, Fowler VG Jr, et al International Collaboration on Endocarditis Study Group. Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database. Clin Infect Dis. 2004;38(9):1323-1327. (Pubitemid 38608579)
22. Tornos P, Almirante B, Olona M, et al. Clinical outcome and long-term prognosis of late prosthetic valve endocarditis: a 20-year experience. Clin Infect Dis. 1997;24(3):381-386. (Pubitemid 27096792)
23. Truninger K, Attenhofer Jost CH, Seifert B, et al. Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone? Heart. 1999;82(6):714-720.
24. Rekik S, Trabelsi I, Maaloul I, et al. Short- and long-term outcomes of surgery for active infective endocarditis: a Tunisian experience. Interact Cardiovasc Thorac Surg. 2009;9(2):241-245.
25. Edwards MB, Ratnatunga CP, Dore CJ, Taylor KM. Thirty-day mortality and long-term survival following surgery for prosthetic endocarditis: a study from the UK heart valve registry. Eur J Cardiothorac Surg. 1998;14(2):156-164. (Pubitemid 28410446)
26. Aksoy O, Sexton DJ, Wang A, et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis. 2007;44(3):364-372. (Pubitemid 46147618)
27. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, et al. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007;115(13):1721-1728. (Pubitemid 46648608)
28. Tleyjeh IM, Steckelberg JM, Georgescu G, et al. The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis. Heart. 2008;94(7):892-896. (Pubitemid 351914701)
29. Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011;32(16):2027-2033.
30. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573-577. (Pubitemid 351664504)
31. Austin PC. Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biom J. 2009;51(1):171-184.
32. Austin PC. The performance of different propensity-scoremethods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies. Stat Med. 2010;29(20):2137-2148.
33. Tleyjeh IM, Kashour T, Zimmerman V, Steckelberg JM, Wilson WR, Baddour LM. The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis. Am Heart J. 2008;156(5):901-909.
34. Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366(26):2466-2473.
35. Cabell CH, Abrutyn E; lessons from the International Collaboration on Endocarditis. Progress toward a global understanding of infective endocarditis. Cardiol Clin. 2003;21(2):147-158.
36. Cabell CH, Abrutyn E. Progress toward a global understanding of infective endocarditis: early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin North Am. 2002;16(2):255-272; vii.
37. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633-638.
38. Fowler VG Jr, Miro JM, Hoen B, et al ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293(24):3012-3021. (Pubitemid 40965071)
39. Benito N, Miró JM, de Lazzari E, et al ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) Investigators. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009;150(9):586-594.
40. Gaca JG, Sheng S, Daneshmand MA, et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg. 2011;141(1):98-106; e101-e102. doi:10.1016/j.jtcvs.2010.09.016.
41. Wang A, Pappas P, Anstrom KJ, et al International Collaboration on Endocarditis Investigators. The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. Am Heart J. 2005;150(5):1086-1091. (Pubitemid 41607803)
42. Kiefer T, Park L, Tribouilloy C, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306(20):2239-2247.